Belgium's Agomab Therapeutics valued at $716 million as shares fall in Nasdaq debut

AgomAb Therapeutics NV ADR -0.43%

AgomAb Therapeutics NV ADR

AGMB

13.85

-0.43%

- Shares of Agomab Therapeutics AGMB.O fell about 8% in their Nasdaq debut on Friday, valuing the Belgium-based company at $716.4 million.


Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via